Serina Therapeutics, Inc.
SER
$1.55
-$0.08-4.91%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -6.85% | 15.83% | |||
| Gross Profit | 6.85% | -20.81% | |||
| SG&A Expenses | 2.37% | 7.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.89% | 12.24% | |||
| Operating Income | 2.89% | -14.86% | |||
| Income Before Tax | 27.79% | 28.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.40% | 28.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -100.00% | -28.57% | |||
| Net Income | 27.24% | 28.89% | |||
| EBIT | 2.89% | -14.86% | |||
| EBITDA | 3.03% | -14.90% | |||
| EPS Basic | 30.21% | 30.94% | |||
| Normalized Basic EPS | 29.73% | 31.20% | |||
| EPS Diluted | 29.96% | 31.33% | |||
| Normalized Diluted EPS | 29.73% | 31.20% | |||
| Average Basic Shares Outstanding | 3.14% | 3.35% | |||
| Average Diluted Shares Outstanding | 3.14% | 3.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||